A new set of treatment options for low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 3:38 6 years ago 404 Далее Скачать
New therapeutic options for low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 2:11 3 years ago 61 Далее Скачать
The promise of luspatercept for the treatment of lower-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 0:56 1 year ago 132 Далее Скачать
Improving the treatment of low-risk MDS: luspatercept, treatment sequencing & disease classification VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 508 Далее Скачать
Treatment algorithm for low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 11:33 4 years ago 281 Далее Скачать
A Unified Approach to Lower Risk MDS: Standard and Emerging Therapies HMP Education 21:55 8 years ago 241 Далее Скачать
The optimal treatment of lower risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 11:53 3 years ago 1 566 Далее Скачать
What are the treatments for low risk and high risk MDS? #MDS HealthTree University for Blood Cancers 4:27 2 years ago 2 890 Далее Скачать
Novel Treatment Strategies in Low-Risk MDS: Challenges and Emerging Therapies HMP Education 18:14 2 years ago 412 Далее Скачать
Debate: Hypomethylating agents are appropriate in lower-risk MDS - Only Use With Caution HMP Education 20:13 8 years ago 202 Далее Скачать
Real-world treatment patterns of patients with low-risk MDS reinitiating ESAs VJHemOnc – Video Journal of Hematology & HemOnc 1:14 2 years ago 116 Далее Скачать
Novel Treatment Strategies in Low-Risk MDS: Case Study HMP Education 18:42 2 years ago 193 Далее Скачать
When is Treatment Needed for Myelodysplastic Syndrome (MDS)? Leukemia Research Foundation 25:30 5 years ago 2 381 Далее Скачать
Update on treatments for high- and low-risk MDS VJHemOnc – Video Journal of Hematology & HemOnc 1:02 4 years ago 143 Далее Скачать